Attached files

file filename
EX-99.2 - FORM OF PROXY CARD - ABVC BIOPHARMA, INC.ea132975ex99-2_american.htm
EX-99.1 - NOTICE TO SHAREHOLDERS - ABVC BIOPHARMA, INC.ea132975ex99-1_american.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 8, 2021

 

AMERICAN BRIVISION (HOLDING) CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   333-91436   26-0014658
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

44370 Old Warm Springs Blvd.

Fremont, CA

  94538
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number including area code: (510) 668-0881

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 7.01: Regulation FD Disclosure

On or about January 8, 2021, American BriVision (Holding) Corporation (the “Company”) mailed a notice to its shareholders regarding the Company’s upcoming annual shareholder meeting. The shareholder meeting will be held on February 8, 2021 at 9:30 p.m., local time in Taiwan (or 8:30 a.m. EST), as a virtual electronic meeting using a Zoom video webinar (the “Meeting”), by accessing the following link: https://zoom.us/webinar/register/WN_Fes0xhX1QgasXwl7tdha6g. Due to concerns regarding the coronavirus pandemic, the Meeting will be held virtually via the Internet only with no physical in-person meeting. The Meeting will be held for the purpose of considering and voting upon several proposals, as set forth in the notice, which is attached hereto as Exhibit 99.1

The notice and related proxy card will be mailed to each shareholder entitled to vote at the annual meeting. Shareholders are urged to read the entire notice as it contains important information about the proposed corporate actions.

After the annual meeting, we will file an amendment to this Report to disclose the voting results.

The information included in Item 7.01 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statement and Exhibits

 

(d) Exhibits

 

No.   Description
99.1   Notice to Shareholders
99.2   Form of Proxy Card

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  American BriVision (Holding) Corporation
     
January 8, 2021 By: /s/ Andy An
    Andy An
    Chief Financial Officer

 

2